Literature DB >> 6336770

A requirement for nonspecific T cell factors in antibody responses to "T cell independent" antigens.

R O Endres, E Kushnir, J W Kappler, P Marrack, S C Kinsky.   

Abstract

Using murine splenic B cell preparations depleted of macrophages and rigorously depleted of T cells, we studied the role of nonspecific helper factors in in vitro antibody responses to T cell-independent (TI) type 1 and type 2 antigens. TNP-lipopolysaccharide, TNP-Brucella abortus, and DNP-liposomes containing lipid A were chosen as examples of TI type 1 antigens. DNP-Ficoll and DNP-liposomes without lipid A were chosen as TI type 2 antigens. Only the type 1 antigens were able to elicit significant, albeit very weak, responses without added helper factors. Both type 1 and 2 antigens required factors present in supernatants from concanavalin A-stimulated spleen cells (Con A SN) to stimulate optimum antibody responses. Interleukin 2- (IL 2) containing supernatant from the T cell hybridoma FS6-14.13 supported suboptimal responses to varying degrees with each TI antigen, in contrast to its lack of effect on responses to sheep red blood cells in the absence of additional factors. This activity of the FS6-14.13 supernatant was removed by absorption with the IL 2-dependent T cell line HT-2, suggesting that IL 2 was the active component. Another factor, IL-X, which is distinct from both IL 1 and IL 2 and is also found in Con A SN, was required in addition to IL 2 to achieve optimal responses with both types of TI antigens. These results clearly establish a role for factors derived from T cells in the activation of B cells by both type 1 and type 2 TI antigens.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6336770

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  14 in total

Review 1.  T lymphocyte dependence of the antibody response to 'T lymphocyte independent type 2' antigens.

Authors:  A Jeurissen; J L Ceuppens; X Bossuyt
Journal:  Immunology       Date:  2004-01       Impact factor: 7.397

Review 2.  Mechanisms of physiologic B cell responses and B cell hyperactivity in systemic lupus erythematosus.

Authors:  R H Zubler; Y P Huang; P A Miescher
Journal:  Springer Semin Immunopathol       Date:  1986

3.  Helper and suppressor activities of an autoreactive mouse thyroglobulin-specific T-cell clone.

Authors:  B R Champion; P Hutchings; S Davies; S Marshall-Clarke; A Cooke; I M Roitt
Journal:  Immunology       Date:  1986-05       Impact factor: 7.397

4.  Identification of a unique B-cell-stimulating factor produced by a cloned dendritic cell.

Authors:  C Clayberger; R H DeKruyff; R Fay; H Cantor
Journal:  Proc Natl Acad Sci U S A       Date:  1985-01       Impact factor: 11.205

5.  Cellular basis of decreased immune responses to pneumococcal vaccines in aged mice.

Authors:  M Garg; W Luo; A M Kaplan; S Bondada
Journal:  Infect Immun       Date:  1996-11       Impact factor: 3.441

6.  Reversing Tolerance in Isotype Switch-Competent Anti-Insulin B Lymphocytes.

Authors:  Jonathan M Williams; Rachel H Bonami; Chrys Hulbert; James W Thomas
Journal:  J Immunol       Date:  2015-06-24       Impact factor: 5.422

7.  The glucuronoxylomannan of Cryptococcus neoformans serotype A is a type 2 T-cell-independent antigen.

Authors:  J B Sundstrom; R Cherniak
Journal:  Infect Immun       Date:  1992-10       Impact factor: 3.441

8.  Serological specificity of phenolic glycolipid I from Mycobacterium leprae and use in serodiagnosis of leprosy.

Authors:  S N Cho; D L Yanagihara; S W Hunter; R H Gelber; P J Brennan
Journal:  Infect Immun       Date:  1983-09       Impact factor: 3.441

9.  T cells or their products are required for the differentiation of precursor B cells into antibody-secreting cells specific for a supposed T-independent self-antigen.

Authors:  S Daenke; K O Cox
Journal:  Immunology       Date:  1987-06       Impact factor: 7.397

10.  Surprisingly uneven distribution of the T cell receptor V beta repertoire in wild mice.

Authors:  A M Pullen; W Potts; E K Wakeland; J Kappler; P Marrack
Journal:  J Exp Med       Date:  1990-01-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.